Pharmaniaga Bhd Completes Rights Issue and Private Placement, Aims to Exit PN17 by 2026
Pharmaniaga Bhd has successfully completed a rights issue and private placement, paving the way for the company to exit its PN17 status and strengthen its position in the Malaysian pharmaceutical market.
3 minutes to read